Hologic Inc. HOLX, +1.33%
shares rose more than 2% in the extended session Monday after the maker
of medical devices said its fiscal third-quarter’s financial outlook
has improved, mainly because one of its units is seeing more revenue
related to COVID-19 tests. Its surgical business has started to recover
faster than the company expected, and its diagnostics business has
outperformed “significantly” thanks to “strong” sales of the company’s
COVID-19 tests, Hologic said. The company said it expects revenue from
the diagnostics business to grow between 20% and 25% in the quarter. Due
to ongoing uncertainty related to the pandemic, however, it would not
quantify longer-term financial effects. Hologic ended the regular
trading day up 1.3%.
https://www.marketwatch.com/story/hologics-financial-outlook-improves-thanks-to-coronavirus-tests-2020-06-08
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.